Search the Newsreel

Kratos Defense Stock Gains 21.4% in 3 Months: Should Investors Buy Now?

Kratos Defense & Security Solutions, Inc.'s KTOS shares have risen 21.4% over the past three months compared with the Zacks Aerospace-Defense Equipment industry's growth of 0.6%. The company maintains a leading position as the U.S. Army's primary supplier of unmanned target drones, with sustained …

Mesa Laboratories (MLAB) Stock Jumps As Margin Gains Meet Backlog Doubts

Mesa Laboratories' stock jumped 9.5% after its Q1 2027 earnings, with investors focusing on improved profitability despite modest revenue growth. Gross margins increased, and cash generation was solid, but net income and EPS declined year-on-year. The company faces risks from backlog issues and customer …

Horace Mann Educators (NYSE:HMN) Raised to "Strong-Buy" at Zacks Research

Abbott Laboratories $ABT Shares Sold by West Branch Capital LLC

West Branch Capital LLC significantly reduced its stake in Abbott Laboratories (NYSE:ABT) by 83.5% in the second quarter, selling 13,061 shares and retaining 2,576 shares worth $234,000. Despite this sell-off, institutional investors collectively own 75.18% of Abbott’s stock. Abbott reported strong Q2 earnings of …

Norges Bank (ATAT) discloses 6.06% ownership in Atour via ADR holdings

Norges Bank, Norway's central bank, has disclosed a 6.06% beneficial ownership stake in Atour Lifestyle Holdings Ltd (ATAT) through its ADR holdings. This amounts to 20,279,628 common shares, with Norges Bank holding sole voting power over all these shares and varying levels of dispositive …

Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Wasatch Advisors LP Invests $72.36 Million in Horace Mann Educators Corporation $HMN

Wasatch Advisors LP has acquired a new position in Horace Mann Educators Corporation (NYSE:HMN), purchasing 1.40 million shares valued at $72.36 million, giving them a 3.47% stake. Horace Mann Educators recently reported strong quarterly earnings, beating analyst estimates, and raised its fiscal 2026 EPS …

Labcorp (LH) Stock Looks About Right On Raised Full Year Guidance

Labcorp (LH) stock appears to be fairly valued according to Discounted Cash Flow and P/E ratio analyses, following a 54.1% increase over the last three years and a recent raise in full-year guidance. The intrinsic value estimate is close to the current share price, …

Caplin Point Laboratories fixes Sept 18 record date for 35th AGM

Charles River Laboratories International, Inc. $CRL Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. significantly reduced its stake in Charles River Laboratories International (NYSE: CRL) by 98.4% in the first quarter, selling over 151,000 shares. Despite this, analyst sentiment remains largely positive, with a consensus "Moderate Buy" rating and a $255.65 average price target. The …

Idexx Laboratories (IDXX) Receives a Buy from Barclays

Asymchem Labs Sets Board Meeting to Approve 2026 Interim Results

Krakatoa Resources Seeks ASX Quotation for 400 Million New Shares

Krakatoa Resources Expands Share Base with Major ASX Issuance

CAPLIPOINT: Q1 FY27 revenue grew 20.7% YoY to ₹644 Crores, with PAT up 18.8% to ₹179 Crores

CAPLIPOINT: Q1 FY27 delivered double-digit revenue and profit growth, with strong expansion in key markets

Butensky & Cohen Financial Security Inc. Purchases 9,277 Shares of Abbott Laboratories $ABT

Butensky & Cohen Financial Security Inc. increased its stake in Abbott Laboratories (NYSE:ABT) by 26.9% in the second quarter, acquiring an additional 9,277 shares to own a total of 43,809 shares valued at $3.98 million. This move comes as Abbott Laboratories reported strong quarterly …

Unichem Laboratories shareholders approve Bhattacharyya reappointment at AGM

Valiant Laboratories Q1 Results: Net profit jumps 422% YoY to ₹9.48 cr

Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Recommendation of "Buy" from Brokerages

Stevanato Group S.p.A. (NYSE:STVN) has received a consensus "Buy" recommendation from six analysts, with two holding, two buying, and two strong buying. Recent analyst coverage includes an "outperform" rating from Wolfe Research with a $21 price target and an upgrade to "strong-buy" from TD …

Atmos Energy Corp (ATO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Q2 Life Insurance Earnings: Horace Mann Educators (NYSE:HMN) Impresses

Q2 Life Insurance Earnings: Horace Mann Educators (NYSE:HMN) Impresses The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let's take a look at how Horace Mann Educators (NYSE:HMN) …

Labcorp Holdings Inc. (NYSE:LH) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Labcorp Holdings Inc. (NYSE:LH) has received a consensus "Moderate Buy" rating from twelve brokerages, with an average 12-month price target of $330.00. The company recently surpassed quarterly earnings expectations with $4.99 EPS and $3.73 billion in revenue, and declared a quarterly dividend of $0.72 …

Navigator Holdings (NVGS) Q2 2026 Earnings Call Transcript

Navigator Holdings (NVGS) reported record Q2 2026 financial results, with net income, EBITDA, and average TCE rates reaching all-time highs. The company benefited from geopolitical disruptions in the Strait of Hormuz, which shifted demand towards North American supply chains for LPG, ethane, and ethylene, …

Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages

Abbott Laboratories (NYSE:ABT) has received a consensus "Moderate Buy" rating from twenty-six brokerages, with an average 12-month price target of $118.17. The company recently exceeded quarterly expectations with adjusted EPS of $1.31 and revenue of $12.59 billion, and announced a quarterly dividend of $0.63 …

Dr. Reddy's Laboratories slides Wednesday, underperforms competitors

Dr. Reddy's Laboratories Ltd. shares fell 0.50% on Wednesday to 1,198.95 Indian rupees, underperforming the broader market as the BSE SENSEX Index dropped 0.24%. The company's stock closed 15.23% below its 52-week high achieved on June 29th.

Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating

Barclays has updated its price target for IDEXX Laboratories (IDXX), lowering it to $710 from the previous $800. Despite this adjustment, the firm has decided to maintain its Overweight rating on the stock. This indicates a continued positive outlook on the company's performance, even …

IDEXX launches in-clinic cardiac test for cats and dogs

IDEXX Laboratories Inc. has launched the Catalyst proBNP Test, an in-clinic diagnostic tool for heart disease in cats and dogs. This test measures the NT-proBNP biomarker, providing rapid quantitative results to veterinarians for screening, diagnosis, and monitoring of cardiac conditions. The test will be …

Avoiding Lag: Real-Time Signals in (NVGS) Movement

Navigator Holdings Ltd. (NASDAQ: NVGS) is showing weak near and mid-term sentiment, potentially challenging its long-term positive outlook. No clear price positioning signal has been identified, and elevated downside risk is noted due to a lack of additional long-term support signals. The article provides …

JHS Svendgaard Laboratories consolidated net profit rises 2.83% in the June 2026 quarter

IDEXX Laboratories (IDXX) Unveils First Dual Species Cardiac Test For Dogs And Cats

Atomera (ATOM) Q2 2026 Earnings Call Transcript

Atomera (ATOM) reported its Q2 2026 earnings, detailing advancements in gate-all-around (GAA) technology with a key customer, expanded opportunities in NAND flash memory, and a significant breakthrough in GaN-on-silicon for RF applications. The company saw revenue of $158,000, a GAAP net loss of $6.3 …

If EPS Growth Is Important To You, Arvee Laboratories (India) (NSE:ARVEE) Presents An Opportunity

¿Puede Abbott Laboratories (ABT) Estar 8% Infravalorada Tras Mejorar Su Previsión Anual?

Bio-Rad (BIO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 5 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Ruben ArguetaChief Executive Officer - Norman SchwartzPresident and Chief Operating Officer - Jonathan DiVincenzoExecutive Vice President and Chief Financial Officer - Roop Lakkaraju …

Kratos (KTOS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 5 p.m. ET CALL PARTICIPANTS Vice President and General Counsel - Marie MendozaPresident and Chief Executive Officer - Eric DeMarcoExecutive Vice President and Chief Financial Officer - Deanna Lund TAKEAWAYS Revenue -- $458.8 …